Medis announces partnership with ACIST in North America

Medis announces partnership with ACIST in North America

The next step for non-invasive angiography in the United States and Canada
We are proud to announce our formal distribution partnership with ACIST to co-market QFR® in the United States and Canada. This partnership is aimed at Medis’ proprietary Quantitative Flow Ratio (QFR®), a novel, non-invasive angiography based physiologic assessment of the presence and extent of coronary artery disease. QFR®provides the healthcare professional with more extensive and quantitative physiologic imaging results to support the patient’s diagnosis and better inform the patient’s treatment. Collaborating with ACIST expands our global reach with a proven, reliable, commercial partner in the US and Canada. This partnership brings us a step closer to our goal; to establish QFR®  as the world’s leading technology in high quality angio-based functional assessments. We are looking forward to work together with ACIST to make QFR® available to healthcare professionals in the US and Canada.Medis, imaging solutions in a heartbeat

Click here for the official press release.

You are about to leave www.medisimaging.com
Medis is not responsible for the content of the external website